AS-FLUDARABINE fludarabine phosphate 50 mg/2 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

as-fludarabine fludarabine phosphate 50 mg/2 ml concentrated injection vial

alphapharm pty ltd - fludarabine phosphate, quantity: 50 mg - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide; mannitol - treatment of b-cell chronic lymphocytic leukaemia.

AS-FLUDARABINE fludarabine phosphate 50 mg powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

as-fludarabine fludarabine phosphate 50 mg powder for injection vial

alphapharm pty ltd - fludarabine phosphate, quantity: 50 mg - injection, powder for - excipient ingredients: mannitol; sodium hydroxide - treatment of b-cell chronic lymphocytic leukaemia.

Fludara 50mg Powder for Solution for Injection or Infusion Malta - English - Medicines Authority

fludara 50mg powder for solution for injection or infusion

genzyme europe bv paasheuvelweg 25, 1105 bp amsterdam , netherlands - fludarabine phosphate - powder for solution for infusion or injection - fludarabine phosphate 25 mg/ml - antineoplastic agents

Fludara oral 10mg film-coated Tablets Malta - English - Medicines Authority

fludara oral 10mg film-coated tablets

genzyme europe bv paasheuvelweg 25, 1105 bp amsterdam , netherlands - fludarabine phosphate - film-coated tablet - fludarabine phosphate 10 mg - antineoplastic agents

Fludara New Zealand - English - Medsafe (Medicines Safety Authority)

fludara

sanofi-aventis new zealand limited - fludarabine phosphate 25 mg/ml;   - powder for injection - 50 mg/2ml - active: fludarabine phosphate 25 mg/ml   excipient: mannitol sodium hydroxide

Fludara oral New Zealand - English - Medsafe (Medicines Safety Authority)

fludara oral

pharmacy retailing (nz) ltd t/a healthcare logistics - fludarabine phosphate 10mg - film coated tablet - 10 mg - active: fludarabine phosphate 10mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose iron oxide red iron oxide yellow lactose monohydrate magnesium stearate microcrystalline cellulose purified talc titanium dioxide - the treatment of b-cell chronic lympocytic leukaemia.

Fludara 50 mg powder for solution for injection or infusion Ireland - English - HPRA (Health Products Regulatory Authority)

fludara 50 mg powder for solution for injection or infusion

genzyme europe b.v. - fludarabine phosphate - powder for solution for injection/infusion - 50 milligram(s) - purine analogues; fludarabine

Fludara 10 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

fludara 10 mg film-coated tablets

genzyme europe b.v. - fludarabine phosphate - film-coated tablet - 10 milligram(s) - purine analogues; fludarabine

Fludara 50 mg inj./inf. sol. (pwdr.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fludara 50 mg inj./inf. sol. (pwdr.) i.v. vial

sanofi b.v. - fludarabine phosphate 50 mg/10 ml - powder for solution for injection/infusion - 50 mg - fludarabine phosphate 50 mg - fludarabine

Fludarabine Teva 25 mg/mL concentrate for solution for injection or infusion Malta - English - Medicines Authority

fludarabine teva 25 mg/ml concentrate for solution for injection or infusion

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - concentrate for solution for infusion or injection - fludarabine phosphate 25 mg/ml - antineoplastic agents